338 related articles for article (PubMed ID: 17308116)
1. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.
Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M
Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116
[TBL] [Abstract][Full Text] [Related]
2. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
3. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
[TBL] [Abstract][Full Text] [Related]
4. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of CD151 gene expression in non-small cell lung cancer.
Tokuhara T; Hasegawa H; Hattori N; Ishida H; Taki T; Tachibana S; Sasaki S; Miyake M
Clin Cancer Res; 2001 Dec; 7(12):4109-14. PubMed ID: 11751509
[TBL] [Abstract][Full Text] [Related]
6. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer.
Higashiyama M; Taki T; Ieki Y; Adachi M; Huang CL; Koh T; Kodama K; Doi O; Miyake M
Cancer Res; 1995 Dec; 55(24):6040-4. PubMed ID: 8521390
[TBL] [Abstract][Full Text] [Related]
7. Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery.
Miyake M; Inufusa H; Adachi M; Ishida H; Hashida H; Tokuhara T; Kakehi Y
Oncogene; 2000 Nov; 19(46):5221-6. PubMed ID: 11077438
[TBL] [Abstract][Full Text] [Related]
8. Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice.
Doki Y; Murakami K; Yamaura T; Sugiyama S; Misaki T; Saiki I
Br J Cancer; 1999 Mar; 79(7-8):1121-6. PubMed ID: 10098745
[TBL] [Abstract][Full Text] [Related]
9. Model for mediastinal lymph node metastasis produced by orthotopic intrapulmonary implantation of lung cancer cells in mice.
Yamaura T; Doki Y; Murakami K; Saiki I
Hum Cell; 1999 Dec; 12(4):197-204. PubMed ID: 10834106
[TBL] [Abstract][Full Text] [Related]
10. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression.
Adachi M; Taki T; Konishi T; Huang CI; Higashiyama M; Miyake M
J Clin Oncol; 1998 Apr; 16(4):1397-406. PubMed ID: 9552043
[TBL] [Abstract][Full Text] [Related]
11. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
12. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
Choi UJ; Jee BK; Lim Y; Lee KH
Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
[TBL] [Abstract][Full Text] [Related]
13. Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
Wu Q; Ji Y; Zhang MQ; Chen YQ; Chen F; Shi DL; Zheng ZH; Huang YJ; Su WJ
Cell Tissue Res; 2003 Nov; 314(2):237-49. PubMed ID: 12955496
[TBL] [Abstract][Full Text] [Related]
14. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
White A; Lamb PW; Barrett JC
Oncogene; 1998 Jun; 16(24):3143-9. PubMed ID: 9671393
[TBL] [Abstract][Full Text] [Related]
15. Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer.
Miyake M; Nakano K; Ieki Y; Adachi M; Huang CL; Itoi S; Koh T; Taki T
Cancer Res; 1995 Sep; 55(18):4127-31. PubMed ID: 7664290
[TBL] [Abstract][Full Text] [Related]
16. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer.
Miyake M; Nakano K; Itoi SI; Koh T; Taki T
Cancer Res; 1996 Mar; 56(6):1244-9. PubMed ID: 8640807
[TBL] [Abstract][Full Text] [Related]
17. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
Huang CI; Kohno N; Ogawa E; Adachi M; Taki T; Miyake M
Am J Pathol; 1998 Sep; 153(3):973-83. PubMed ID: 9736046
[TBL] [Abstract][Full Text] [Related]
18. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
19. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer.
Funakoshi T; Tachibana I; Hoshida Y; Kimura H; Takeda Y; Kijima T; Nishino K; Goto H; Yoneda T; Kumagai T; Osaki T; Hayashi S; Aozasa K; Kawase I
Oncogene; 2003 Feb; 22(5):674-87. PubMed ID: 12569360
[TBL] [Abstract][Full Text] [Related]
20. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
